ARLINGTON, Va., June 10, 2025 -- IMV Info, a prominent data and analytics provider in the medical imaging sector, was cited in a new study published in JAMA Internal Medicine (DOI: 10.1001/jamainternmed.2024.6340), which projects long-term cancer risks associated with current computed tomography (CT) scan utilization in the U.S. .
Key Findings from the Study
- The peer-reviewed analysis models the projected lifetime incidence of cancers stemming from routine CT scan practices across the United States.
- Notably, children face elevated risks, with projected incidences of thyroid, lung, and breast cancers due to ionizing radiation exposure.
- The study aligns with growing medical concerns around cumulative radiation exposure from diagnostic imaging.
IMV Info provided validated dataset inputs on CT examinations by age group—crucial parameters for the study's cancer risk modeling. This real-world source underpinned the study's credibility and sensitivity analyses.
"Combining large-scale data collection with rigorous modeling helps analysts understand the real-world impact of medical imaging," said Davin Korstjens, Director of Market Intelligence at IMV. "We're proud that our analytics were selected to support this powerful examination of patient safety and diagnostic best practices."
Read the full article here.
About IMV Info
IMV Info is a data-driven intelligence leader in the radiology and imaging market. It supplies analytics on diagnostic equipment usage, modality trends, and data-informed support for informed, safe healthcare decisions.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
